175 related articles for article (PubMed ID: 35050428)
1. SARS-CoV-2 vaccine-related neurological complications.
Oonk NGM; Ettema AR; van Berghem H; de Klerk JJ; van der Vegt JPM; van der Meulen M
Neurol Sci; 2022 Apr; 43(4):2295-2297. PubMed ID: 35050428
[TBL] [Abstract][Full Text] [Related]
2. SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study.
Luchetti Gentiloni MM; Paci V; Marconi V; Gigli M; Benfaremo D; Sordillo R; Macchini C; Massaccesi L; Perna GP; Offidani AM; Moroncini G
Front Immunol; 2022; 13():859550. PubMed ID: 35386714
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine.
Lombardi A; Renisi G; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Gori A; Bandera A
BMC Infect Dis; 2022 Jan; 22(1):97. PubMed ID: 35090388
[TBL] [Abstract][Full Text] [Related]
5. Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion.
Pla Peris B; Merchante Alfaro AÁ; Maravall Royo FJ; Abellán Galiana P; Pérez Naranjo S; González Boillos M
J Endocrinol Invest; 2022 May; 45(5):1071-1077. PubMed ID: 35015288
[TBL] [Abstract][Full Text] [Related]
6. Chorea following SARS-CoV-2 infection and vaccination: a systematic review of reported cases.
Rosca EC; Bilavu R; Cornea A; Simu M
Int J Infect Dis; 2023 Sep; 134():256-260. PubMed ID: 37423421
[TBL] [Abstract][Full Text] [Related]
7. Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients.
Gerhard A; Raeder V; Pernice HF; Boesl F; Schroeder M; Richter J; Endres M; Prüß H; Hahn K; Audebert HJ; Franke C
J Neurol; 2023 Oct; 270(10):4673-4677. PubMed ID: 37515731
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
9. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.
Mitsikostas DD; Caronna E; De Tommaso M; Deligianni CI; Ekizoglu E; Bolay H; Göbel CH; Kristoffersen ES; Lampl C; Moro E; Pozo-Rosich P; Sellner J; Terwindt G; Irimia-Sieira P
Eur J Neurol; 2024 Jun; 31(6):e16251. PubMed ID: 38415282
[TBL] [Abstract][Full Text] [Related]
10. The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review.
Tavazzi E; Pichiecchio A; Colombo E; Rigoni E; Asteggiano C; Vegezzi E; Masi F; Greco G; Bastianello S; Bergamaschi R
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515255
[TBL] [Abstract][Full Text] [Related]
11. Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination.
Jain E; Donowitz JR; Aarons E; Marshall BC; Miller MP
Emerg Infect Dis; 2022 May; 28(5):990-993. PubMed ID: 35275051
[TBL] [Abstract][Full Text] [Related]
12. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
[TBL] [Abstract][Full Text] [Related]
13. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders.
Dinoto A; Gastaldi M; Iorio R; Marini S; Damato V; Farina A; Zoccarato M; Sechi E; Pinna F; Maniscalco GT; Barnabei R; Zuliani L; Ferrari S; Mariotto S
Mult Scler Relat Disord; 2022 Jul; 63():103827. PubMed ID: 35508101
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
Briggs FBS; Mateen FJ; Schmidt H; Currie KM; Siefers HM; Crouthamel S; Bebo BF; Fiol J; Racke MK; O'Connor KC; Kolaczkowski LG; Klein P; Loud S; McBurney RN
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34753828
[TBL] [Abstract][Full Text] [Related]
17. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.
Ramdas S; Hum RM; Price A; Paul A; Bland J; Burke G; Farrugia M; Palace J; Storrie A; Ho P; Standing E; Lilleker JB; Jungbluth H
Neuromuscul Disord; 2022 Oct; 32(10):785-789. PubMed ID: 36130855
[TBL] [Abstract][Full Text] [Related]
19. Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination.
De Michele M; Kahan J; Berto I; Schiavo OG; Iacobucci M; Toni D; Merkler AE
Circ Res; 2022 Apr; 130(8):1187-1203. PubMed ID: 35420916
[TBL] [Abstract][Full Text] [Related]
20. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
